BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12446428)

  • 1. Central nervous system lymphoma.
    Lister A; Abrey LE; Sandlund JT
    Hematology Am Soc Hematol Educ Program; 2002; ():283-96. PubMed ID: 12446428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of primary central nervous system lymphoma.
    Royer-Perron L; Hoang-Xuan K
    Presse Med; 2018; 47(11-12 Pt 2):e213-e244. PubMed ID: 30416008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary central nervous system lymphoma.
    Gallop-Evans E
    Clin Oncol (R Coll Radiol); 2012 Jun; 24(5):329-38. PubMed ID: 22459053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS prophylaxis in lymphoma: who to target and what therapy to use.
    Hill QA; Owen RG
    Blood Rev; 2006 Nov; 20(6):319-32. PubMed ID: 16884838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Primary Central Nervous System Lymphoma.
    Patrick LB; Mohile NA
    Curr Oncol Rep; 2015 Dec; 17(12):60. PubMed ID: 26475775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual variants of primary central nervous system lymphoma.
    Shenkier TN
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):651-64, vi. PubMed ID: 16083828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary ocular lymphoma: clinical features, diagnosis, and treatment.
    Hormigo A; DeAngelis LM
    Clin Lymphoma; 2003 Jun; 4(1):22-9. PubMed ID: 12837150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary central nervous system lymphoma.
    Mohile NA; Abrey LE
    Neurol Clin; 2007 Nov; 25(4):1193-207, xi. PubMed ID: 17964031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature.
    Izquierdo C; Velasco R; Vidal N; Sánchez JJ; Argyriou AA; Besora S; Graus F; Bruna J
    Neuro Oncol; 2016 May; 18(5):707-15. PubMed ID: 26415875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary central nervous system lymphoma.
    Stern JI; Raizer JJ
    Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S63-70. PubMed ID: 16274272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary central nervous system lymphoma: diagnosis, management and current topics].
    Arita N
    No To Shinkei; 2004 Mar; 56(3):195-203. PubMed ID: 15112444
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary CNS lymphoma.
    Hochberg FH; Baehring JM; Hochberg EP
    Nat Clin Pract Neurol; 2007 Jan; 3(1):24-35. PubMed ID: 17205072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current management of primary central nervous system lymphoma.
    Schultz CJ; Bovi J
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary central nervous system lymphoma and subcutaneous metastases.
    Al Bahrani B; Henderson C; Delaney G
    J Neurooncol; 2000 Apr; 47(2):141-4. PubMed ID: 10982155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociated evolution of a multifocal primary CNS lymphoma.
    Bagacean C; Zdrenghea M; Popescu C; Quintin-Roue I; Ianotto JC; Eveillard JR; Berthou C; Tempescul A
    J BUON; 2013; 18(4):1098. PubMed ID: 24344046
    [No Abstract]   [Full Text] [Related]  

  • 16. A rare presentation of hypertrophic olivary degeneration secondary to primary central nervous system lymphoma.
    Cachia D; Izzy S; Smith T; Ionete C
    JAMA Neurol; 2013 Sep; 70(9):1192-3. PubMed ID: 23857254
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary central nervous lymphoma: what is the role for radiotherapy?].
    Bellefqih S; Mezouri I; Khalil J; Bazine A; Diakité A; El Kacimi H; Kebdani T; Benjaafar N
    Cancer Radiother; 2014 Nov; 18(7):685-92. PubMed ID: 25451676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system lymphoma.
    Ferreri AJ; Reni M
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.
    Scordo M; Bhatt V; Hsu M; Omuro AM; Matasar MJ; DeAngelis LM; Dahi PB; Moskowitz CH; Giralt SA; Sauter CS
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):38-43. PubMed ID: 27713090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary central nervous system lymphoma as a neurosurgical problem.
    Szczepanek D; Wąsik-Szczepanek E; Stoma F; Sokołowska B; Trojanowski T
    Neurol Neurochir Pol; 2017; 51(4):319-323. PubMed ID: 28476199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.